BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24558125)

  • 1. Mantra 2.0: an online collaborative resource for drug mode of action and repurposing by network analysis.
    Carrella D; Napolitano F; Rispoli R; Miglietta M; Carissimo A; Cutillo L; Sirci F; Gregoretti F; Di Bernardo D
    Bioinformatics; 2014 Jun; 30(12):1787-8. PubMed ID: 24558125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of drug mode of action and drug repositioning from transcriptional responses.
    Iorio F; Bosotti R; Scacheri E; Belcastro V; Mithbaokar P; Ferriero R; Murino L; Tagliaferri R; Brunetti-Pierri N; Isacchi A; di Bernardo D
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14621-6. PubMed ID: 20679242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DvD: An R/Cytoscape pipeline for drug repurposing using public repositories of gene expression data.
    Pacini C; Iorio F; Gonçalves E; Iskar M; Klabunde T; Bork P; Saez-Rodriguez J
    Bioinformatics; 2013 Jan; 29(1):132-4. PubMed ID: 23129297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gene2drug: a computational tool for pathway-based rational drug repositioning.
    Napolitano F; Carrella D; Mandriani B; Pisonero-Vaquero S; Sirci F; Medina DL; Brunetti-Pierri N; di Bernardo D
    Bioinformatics; 2018 May; 34(9):1498-1505. PubMed ID: 29236977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.
    Jia Z; Liu Y; Guan N; Bo X; Luo Z; Barnes MR
    BMC Genomics; 2016 May; 17():414. PubMed ID: 27234029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Application of Computational Drug Repurposing Based on Transcriptomic Signatures.
    Karatzas E; Kolios G; Spyrou GM
    Methods Mol Biol; 2019; 1903():149-177. PubMed ID: 30547441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing Using Deep Embeddings of Gene Expression Profiles.
    Donner Y; Kazmierczak S; Fortney K
    Mol Pharm; 2018 Oct; 15(10):4314-4325. PubMed ID: 30001141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of chemical mechanism of action via an improved network-based inference method.
    Wu Z; Lu W; Wu D; Luo A; Bian H; Li J; Li W; Liu G; Huang J; Cheng F; Tang Y
    Br J Pharmacol; 2016 Dec; 173(23):3372-3385. PubMed ID: 27646592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning.
    Setoain J; Franch M; Martínez M; Tabas-Madrid D; Sorzano CO; Bakker A; Gonzalez-Couto E; Elvira J; Pascual-Montano A
    Nucleic Acids Res; 2015 Jul; 43(W1):W193-9. PubMed ID: 25940629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Web-based drug repurposing tools: a survey.
    Sam E; Athri P
    Brief Bioinform; 2019 Jan; 20(1):299-316. PubMed ID: 29028878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
    Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
    Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Data-driven drug discovery for drug repurposing].
    Saito R; Yano N; Kojima S; Miyoshi F
    Nihon Yakurigaku Zasshi; 2023; 158(1):10-14. PubMed ID: 36596476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open MoA: revealing the mechanism of action (MoA) based on network topology and hierarchy.
    Liao X; Ozcan M; Shi M; Kim W; Jin H; Li X; Turkez H; Achour A; Uhlén M; Mardinoglu A; Zhang C
    Bioinformatics; 2023 Nov; 39(11):. PubMed ID: 37930015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics Data Integration and Analysis for Systems Pharmacology.
    Lim H; Xie L
    Methods Mol Biol; 2019; 1939():199-214. PubMed ID: 30848463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BalestraWeb: efficient online evaluation of drug-target interactions.
    Cobanoglu MC; Oltvai ZN; Taylor DL; Bahar I
    Bioinformatics; 2015 Jan; 31(1):131-3. PubMed ID: 25192741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing: a promising tool to accelerate the drug discovery process.
    Parvathaneni V; Kulkarni NS; Muth A; Gupta V
    Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How good are publicly available web services that predict bioactivity profiles for drug repurposing?
    Murtazalieva KA; Druzhilovskiy DS; Goel RK; Sastry GN; Poroikov VV
    SAR QSAR Environ Res; 2017 Oct; 28(10):843-862. PubMed ID: 29183230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
    Turanli B; Gulfidan G; Arga KY
    OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.